AXA SA (CS.PA) Stock Fundamental Analysis
Europe - EPA:CS - FR0000120628 - Common Stock
39.89 EUR
+0.31 (+0.78%)
Taking everything into account, CS scores 5 out of 10 in our fundamental rating. CS was compared to 43 industry peers in the Insurance industry. Both the profitability and the financial health of CS get a neutral evaluation. Nothing too spectacular is happening here. CS has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CS was profitable.
CS had a positive operating cash flow in the past year.
Each year in the past 5 years CS has been profitable.
CS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CS's Return On Assets of 1.18% is in line compared to the rest of the industry. CS outperforms 53.49% of its industry peers.
CS has a better Return On Equity (16.72%) than 67.44% of its industry peers.
CS has a Return On Invested Capital of 1.28%. This is comparable to the rest of the industry: CS outperforms 55.81% of its industry peers.
CS had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROIC | 1.28% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
The Profit Margin of CS (8.52%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CS has grown nicely.
CS has a Operating Margin (11.47%) which is comparable to the rest of the industry.
CS's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
Compared to 1 year ago, CS has less shares outstanding
CS has less shares outstanding than it did 5 years ago.
CS has a worse debt/assets ratio than last year.
2.2 Solvency
CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
CS has a Altman-Z score of 0.35. This is amongst the best in the industry. CS outperforms 90.70% of its industry peers.
The Debt to FCF ratio of CS is 1.41, which is an excellent value as it means it would take CS, only 1.41 years of fcf income to pay off all of its debts.
CS's Debt to FCF ratio of 1.41 is fine compared to the rest of the industry. CS outperforms 79.07% of its industry peers.
CS has a Debt/Equity ratio of 0.65. This is a neutral value indicating CS is somewhat dependend on debt financing.
CS has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: CS outperforms 51.16% of its industry peers.
Although CS does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.12
WACC10.56%
2.3 Liquidity
CS has a Current Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
CS has a Current ratio of 0.82. This is amongst the best in the industry. CS outperforms 88.37% of its industry peers.
A Quick Ratio of 0.82 indicates that CS may have some problems paying its short term obligations.
CS has a Quick ratio of 0.82. This is amongst the best in the industry. CS outperforms 88.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.70% over the past year.
The Earnings Per Share has been growing by 18.09% on average over the past years. This is quite good.
The Revenue has been growing slightly by 4.40% in the past year.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
3.2 Future
The Earnings Per Share is expected to grow by 6.80% on average over the next years.
CS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.8%
Revenue Next Year8.83%
Revenue Next 2Y6.98%
Revenue Next 3Y7.01%
Revenue Next 5Y8.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.64, the valuation of CS can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 76.74% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. CS is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.34, the valuation of CS can be described as very reasonable.
76.74% of the companies in the same industry are more expensive than CS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CS to the average of the S&P500 Index (22.86), we can say CS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 9.34 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, CS is valued cheaply inside the industry as 86.05% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.13 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)0.59
EPS Next 2Y9.06%
EPS Next 3Y8.11%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.34%, CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.56, CS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, CS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
5.2 History
The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
61.79% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPA:CS (9/19/2025, 7:00:00 PM)
39.89
+0.31 (+0.78%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap86.49B
Analysts81.48
Price Target45.46 (13.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.34% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.53%
PT rev (3m)3.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.7%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.48%
Revenue NY rev (3m)2.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 9.34 | ||
| P/S | 0.97 | ||
| P/FCF | 4.13 | ||
| P/OCF | 4.04 | ||
| P/B | 1.9 | ||
| P/tB | 3.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.75
EY9.4%
EPS(NY)4.27
Fwd EY10.7%
FCF(TTM)9.65
FCFY24.2%
OCF(TTM)9.87
OCFY24.74%
SpS41.17
BVpS20.98
TBVpS11.12
PEG (NY)0.73
PEG (5Y)0.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 16.72% | ||
| ROCE | 1.62% | ||
| ROIC | 1.28% | ||
| ROICexc | 1.33% | ||
| ROICexgc | 1.74% | ||
| OM | 11.47% | ||
| PM (TTM) | 8.52% | ||
| GM | N/A | ||
| FCFM | 23.44% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 1.41 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.53% | ||
| Interest Coverage | 1.98 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 275.1% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.56%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
EPS Next Y14.58%
EPS Next 2Y9.06%
EPS Next 3Y8.11%
EPS Next 5Y6.8%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
Revenue Next Year8.83%
Revenue Next 2Y6.98%
Revenue Next 3Y7.01%
Revenue Next 5Y8.27%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%